Global Pet Anthelmintic Drugs Market Size, Status and Forecast 2024-2031

Report ID: 920022 | Published Date: Jan 2025 | No. of Page: 124 | Base Year: 2024 | Rating: 4.2 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Pet Anthelmintic Drugs Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
        1.2.2 External
        1.2.3 Internal
        1.2.4 Composite
        1.2.5 Injection
    1.3 Market by Application
        1.3.1 Global Pet Anthelmintic Drugs Market Share by Application: 2016 VS 2021 VS 2027
        1.3.2 Dog
        1.3.3 Cat
        1.3.4 Others
    1.4 Study Objectives
    1.5 Years Considered

2 Global Growth Trends
    2.1 Global Pet Anthelmintic Drugs Market Perspective (2016-2027)
    2.2 Pet Anthelmintic Drugs Growth Trends by Regions
        2.2.1 Pet Anthelmintic Drugs Market Size by Regions: 2016 VS 2021 VS 2027
        2.2.2 Pet Anthelmintic Drugs Historic Market Share by Regions (2016-2021)
        2.2.3 Pet Anthelmintic Drugs Forecasted Market Size by Regions (2022-2027)
    2.3 Pet Anthelmintic Drugs Industry Dynamic
        2.3.1 Pet Anthelmintic Drugs Market Trends
        2.3.2 Pet Anthelmintic Drugs Market Drivers
        2.3.3 Pet Anthelmintic Drugs Market Challenges
        2.3.4 Pet Anthelmintic Drugs Market Restraints

3 Competition Landscape by Key Players
    3.1 Global Top Pet Anthelmintic Drugs Players by Revenue
        3.1.1 Global Top Pet Anthelmintic Drugs Players by Revenue (2016-2021)
        3.1.2 Global Pet Anthelmintic Drugs Revenue Market Share by Players (2016-2021)
    3.2 Global Pet Anthelmintic Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    3.3 Players Covered: Ranking by Pet Anthelmintic Drugs Revenue
    3.4 Global Pet Anthelmintic Drugs Market Concentration Ratio
        3.4.1 Global Pet Anthelmintic Drugs Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Pet Anthelmintic Drugs Revenue in 2020
    3.5 Pet Anthelmintic Drugs Key Players Head office and Area Served
    3.6 Key Players Pet Anthelmintic Drugs Product Solution and Service
    3.7 Date of Enter into Pet Anthelmintic Drugs Market
    3.8 Mergers & Acquisitions, Expansion Plans

4 Pet Anthelmintic Drugs Breakdown Data by Type
    4.1 Global Pet Anthelmintic Drugs Historic Market Size by Type (2016-2021)
    4.2 Global Pet Anthelmintic Drugs Forecasted Market Size by Type (2022-2027)

5 Pet Anthelmintic Drugs Breakdown Data by Application
    5.1 Global Pet Anthelmintic Drugs Historic Market Size by Application (2016-2021)
    5.2 Global Pet Anthelmintic Drugs Forecasted Market Size by Application (2022-2027)

6 North America
    6.1 North America Pet Anthelmintic Drugs Market Size (2016-2027)
    6.2 North America Pet Anthelmintic Drugs Market Size by Type
        6.2.1 North America Pet Anthelmintic Drugs Market Size by Type (2016-2021)
        6.2.2 North America Pet Anthelmintic Drugs Market Size by Type (2022-2027)
        6.2.3 North America Pet Anthelmintic Drugs Market Size by Type (2016-2027)
    6.3 North America Pet Anthelmintic Drugs Market Size by Application
        6.3.1 North America Pet Anthelmintic Drugs Market Size by Application (2016-2021)
        6.3.2 North America Pet Anthelmintic Drugs Market Size by Application (2022-2027)
        6.3.3 North America Pet Anthelmintic Drugs Market Size by Application (2016-2027)
    6.4 North America Pet Anthelmintic Drugs Market Size by Country
        6.4.1 North America Pet Anthelmintic Drugs Market Size by Country (2016-2021)
        6.4.2 North America Pet Anthelmintic Drugs Market Size by Country (2022-2027)
        6.4.3 United States
        6.4.4 Canada

7 Europe
    7.1 Europe Pet Anthelmintic Drugs Market Size (2016-2027)
    7.2 Europe Pet Anthelmintic Drugs Market Size by Type
        7.2.1 Europe Pet Anthelmintic Drugs Market Size by Type (2016-2021)
        7.2.2 Europe Pet Anthelmintic Drugs Market Size by Type (2022-2027)
        7.2.3 Europe Pet Anthelmintic Drugs Market Size by Type (2016-2027)
    7.3 Europe Pet Anthelmintic Drugs Market Size by Application
        7.3.1 Europe Pet Anthelmintic Drugs Market Size by Application (2016-2021)
        7.3.2 Europe Pet Anthelmintic Drugs Market Size by Application (2022-2027)
        7.3.3 Europe Pet Anthelmintic Drugs Market Size by Application (2016-2027)
    7.4 Europe Pet Anthelmintic Drugs Market Size by Country
        7.4.1 Europe Pet Anthelmintic Drugs Market Size by Country (2016-2021)
        7.4.2 Europe Pet Anthelmintic Drugs Market Size by Country (2022-2027)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic

8 Asia-Pacific
    8.1 Asia-Pacific Pet Anthelmintic Drugs Market Size (2016-2027)
    8.2 Asia-Pacific Pet Anthelmintic Drugs Market Size by Type
        8.2.1 Asia-Pacific Pet Anthelmintic Drugs Market Size by Type (2016-2021)
        8.2.2 Asia-Pacific Pet Anthelmintic Drugs Market Size by Type (2022-2027)
        8.2.3 Asia-Pacific Pet Anthelmintic Drugs Market Size by Type (2016-2027)
    8.3 Asia-Pacific Pet Anthelmintic Drugs Market Size by Application
        8.3.1 Asia-Pacific Pet Anthelmintic Drugs Market Size by Application (2016-2021)
        8.3.2 Asia-Pacific Pet Anthelmintic Drugs Market Size by Application (2022-2027)
        8.3.3 Asia-Pacific Pet Anthelmintic Drugs Market Size by Application (2016-2027)
    8.4 Asia-Pacific Pet Anthelmintic Drugs Market Size by Region
        8.4.1 Asia-Pacific Pet Anthelmintic Drugs Market Size by Region (2016-2021)
        8.4.2 Asia-Pacific Pet Anthelmintic Drugs Market Size by Region (2022-2027)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia

9 Latin America
    9.1 Latin America Pet Anthelmintic Drugs Market Size (2016-2027)
    9.2 Latin America Pet Anthelmintic Drugs Market Size by Type
        9.2.1 Latin America Pet Anthelmintic Drugs Market Size by Type (2016-2021)
        9.2.2 Latin America Pet Anthelmintic Drugs Market Size by Type (2022-2027)
        9.2.3 Latin America Pet Anthelmintic Drugs Market Size by Type (2016-2027)
    9.3 Latin America Pet Anthelmintic Drugs Market Size by Application
        9.3.1 Latin America Pet Anthelmintic Drugs Market Size by Application (2016-2021)
        9.3.2 Latin America Pet Anthelmintic Drugs Market Size by Application (2022-2027)
        9.3.3 Latin America Pet Anthelmintic Drugs Market Size by Application (2016-2027)
    9.4 Latin America Pet Anthelmintic Drugs Market Size by Country
        9.4.1 Latin America Pet Anthelmintic Drugs Market Size by Country (2016-2021)
        9.4.2 Latin America Pet Anthelmintic Drugs Market Size by Country (2022-2027)
        9.4.3 Mexico
        9.4.4 Brazil

10 Middle East & Africa
    10.1 Middle East & Africa Pet Anthelmintic Drugs Market Size (2016-2027)
    10.2 Middle East & Africa Pet Anthelmintic Drugs Market Size by Type
        10.2.1 Middle East & Africa Pet Anthelmintic Drugs Market Size by Type (2016-2021)
        10.2.2 Middle East & Africa Pet Anthelmintic Drugs Market Size by Type (2022-2027)
        10.2.3 Middle East & Africa Pet Anthelmintic Drugs Market Size by Type (2016-2027)
    10.3 Middle East & Africa Pet Anthelmintic Drugs Market Size by Application
        10.3.1 Middle East & Africa Pet Anthelmintic Drugs Market Size by Application (2016-2021)
        10.3.2 Middle East & Africa Pet Anthelmintic Drugs Market Size by Application (2022-2027)
        10.3.3 Middle East & Africa Pet Anthelmintic Drugs Market Size by Application (2016-2027)
    10.4 Middle East & Africa Pet Anthelmintic Drugs Market Size by Country
        10.4.1 Middle East & Africa Pet Anthelmintic Drugs Market Size by Country (2016-2021)
        10.4.2 Middle East & Africa Pet Anthelmintic Drugs Market Size by Country (2022-2027)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE

11 Key Players Profiles
    11.1 Elanco
        11.1.1 Elanco Company Details
        11.1.2 Elanco Business Overview
        11.1.3 Elanco Pet Anthelmintic Drugs Introduction
        11.1.4 Elanco Revenue in Pet Anthelmintic Drugs Business (2016-2021)
        11.1.5 Elanco Recent Development
    11.2 Boehringer Ingelheim
        11.2.1 Boehringer Ingelheim Company Details
        11.2.2 Boehringer Ingelheim Business Overview
        11.2.3 Boehringer Ingelheim Pet Anthelmintic Drugs Introduction
        11.2.4 Boehringer Ingelheim Revenue in Pet Anthelmintic Drugs Business (2016-2021)
        11.2.5 Boehringer Ingelheim Recent Development
    11.3 Ceva Sante Animale
        11.3.1 Ceva Sante Animale Company Details
        11.3.2 Ceva Sante Animale Business Overview
        11.3.3 Ceva Sante Animale Pet Anthelmintic Drugs Introduction
        11.3.4 Ceva Sante Animale Revenue in Pet Anthelmintic Drugs Business (2016-2021)
        11.3.5 Ceva Sante Animale Recent Development
    11.4 Chanelle Group
        11.4.1 Chanelle Group Company Details
        11.4.2 Chanelle Group Business Overview
        11.4.3 Chanelle Group Pet Anthelmintic Drugs Introduction
        11.4.4 Chanelle Group Revenue in Pet Anthelmintic Drugs Business (2016-2021)
        11.4.5 Chanelle Group Recent Development
    11.5 Dechra
        11.5.1 Dechra Company Details
        11.5.2 Dechra Business Overview
        11.5.3 Dechra Pet Anthelmintic Drugs Introduction
        11.5.4 Dechra Revenue in Pet Anthelmintic Drugs Business (2016-2021)
        11.5.5 Dechra Recent Development
    11.6 Durvet
        11.6.1 Durvet Company Details
        11.6.2 Durvet Business Overview
        11.6.3 Durvet Pet Anthelmintic Drugs Introduction
        11.6.4 Durvet Revenue in Pet Anthelmintic Drugs Business (2016-2021)
        11.6.5 Durvet Recent Development
    11.7 First Priority
        11.7.1 First Priority Company Details
        11.7.2 First Priority Business Overview
        11.7.3 First Priority Pet Anthelmintic Drugs Introduction
        11.7.4 First Priority Revenue in Pet Anthelmintic Drugs Business (2016-2021)
        11.7.5 First Priority Recent Development
    11.8 Jeffers
        11.8.1 Jeffers Company Details
        11.8.2 Jeffers Business Overview
        11.8.3 Jeffers Pet Anthelmintic Drugs Introduction
        11.8.4 Jeffers Revenue in Pet Anthelmintic Drugs Business (2016-2021)
        11.8.5 Jeffers Recent Development
    11.9 Manna Pro Products
        11.9.1 Manna Pro Products Company Details
        11.9.2 Manna Pro Products Business Overview
        11.9.3 Manna Pro Products Pet Anthelmintic Drugs Introduction
        11.9.4 Manna Pro Products Revenue in Pet Anthelmintic Drugs Business (2016-2021)
        11.9.5 Manna Pro Products Recent Development
    11.10 Merck Animal Health
        11.10.1 Merck Animal Health Company Details
        11.10.2 Merck Animal Health Business Overview
        11.10.3 Merck Animal Health Pet Anthelmintic Drugs Introduction
        11.10.4 Merck Animal Health Revenue in Pet Anthelmintic Drugs Business (2016-2021)
        11.10.5 Merck Animal Health Recent Development
    11.11 Ourofino
        11.11.1 Ourofino Company Details
        11.11.2 Ourofino Business Overview
        11.11.3 Ourofino Pet Anthelmintic Drugs Introduction
        11.11.4 Ourofino Revenue in Pet Anthelmintic Drugs Business (2016-2021)
        11.11.5 Ourofino Recent Development
    11.12 TTK Healthcare
        11.12.1 TTK Healthcare Company Details
        11.12.2 TTK Healthcare Business Overview
        11.12.3 TTK Healthcare Pet Anthelmintic Drugs Introduction
        11.12.4 TTK Healthcare Revenue in Pet Anthelmintic Drugs Business (2016-2021)
        11.12.5 TTK Healthcare Recent Development
    11.13 Vetoquinol
        11.13.1 Vetoquinol Company Details
        11.13.2 Vetoquinol Business Overview
        11.13.3 Vetoquinol Pet Anthelmintic Drugs Introduction
        11.13.4 Vetoquinol Revenue in Pet Anthelmintic Drugs Business (2016-2021)
        11.13.5 Vetoquinol Recent Development
    11.14 Virbac
        11.14.1 Virbac Company Details
        11.14.2 Virbac Business Overview
        11.14.3 Virbac Pet Anthelmintic Drugs Introduction
        11.14.4 Virbac Revenue in Pet Anthelmintic Drugs Business (2016-2021)
        11.14.5 Virbac Recent Development
    11.15 Zoetis
        11.15.1 Zoetis Company Details
        11.15.2 Zoetis Business Overview
        11.15.3 Zoetis Pet Anthelmintic Drugs Introduction
        11.15.4 Zoetis Revenue in Pet Anthelmintic Drugs Business (2016-2021)
        11.15.5 Zoetis Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details
List of Tables
    Table 1. Global Pet Anthelmintic Drugs Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
    Table 2. Key Players of External
    Table 3. Key Players of Internal
    Table 4. Key Players of Composite
    Table 5. Key Players of Injection
    Table 6. Global Pet Anthelmintic Drugs Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
    Table 7. Global Pet Anthelmintic Drugs Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
    Table 8. Global Pet Anthelmintic Drugs Market Size by Regions (2016-2021) & (US$ Million)
    Table 9. Global Pet Anthelmintic Drugs Market Share by Regions (2016-2021)
    Table 10. Global Pet Anthelmintic Drugs Forecasted Market Size by Regions (2022-2027) & (US$ Million)
    Table 11. Global Pet Anthelmintic Drugs Market Share by Regions (2022-2027)
    Table 12. Pet Anthelmintic Drugs Market Trends
    Table 13. Pet Anthelmintic Drugs Market Drivers
    Table 14. Pet Anthelmintic Drugs Market Challenges
    Table 15. Pet Anthelmintic Drugs Market Restraints
    Table 16. Global Pet Anthelmintic Drugs Revenue by Players (2016-2021) & (US$ Million)
    Table 17. Global Pet Anthelmintic Drugs Market Share by Players (2016-2021)
    Table 18. Global Top Pet Anthelmintic Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pet Anthelmintic Drugs as of 2020)
    Table 19. Ranking of Global Top Pet Anthelmintic Drugs Companies by Revenue (US$ Million) in 2020
    Table 20. Global 5 Largest Players Market Share by Pet Anthelmintic Drugs Revenue (CR5 and HHI) & (2016-2021)
    Table 21. Key Players Headquarters and Area Served
    Table 22. Key Players Pet Anthelmintic Drugs Product Solution and Service
    Table 23. Date of Enter into Pet Anthelmintic Drugs Market
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Pet Anthelmintic Drugs Market Size by Type (2016-2021) (US$ Million)
    Table 26. Global Pet Anthelmintic Drugs Revenue Market Share by Type (2016-2021)
    Table 27. Global Pet Anthelmintic Drugs Forecasted Market Size by Type (2022-2027) (US$ Million)
    Table 28. Global Pet Anthelmintic Drugs Revenue Market Share by Type (2022-2027) & (US$ Million)
    Table 29. Global Pet Anthelmintic Drugs Market Size Share by Application (2016-2021) & (US$ Million)
    Table 30. Global Pet Anthelmintic Drugs Revenue Market Share by Application (2016-2021)
    Table 31. Global Pet Anthelmintic Drugs Forecasted Market Size by Application (2022-2027) (US$ Million)
    Table 32. Global Pet Anthelmintic Drugs Revenue Market Share by Application (2022-2027) & (US$ Million)
    Table 33. North America Pet Anthelmintic Drugs Market Size by Type (2016-2021) (US$ Million)
    Table 34. North America Pet Anthelmintic Drugs Market Size by Type (2022-2027) & (US$ Million)
    Table 35. North America Pet Anthelmintic Drugs Market Size by Application (2016-2021) (US$ Million)
    Table 36. North America Pet Anthelmintic Drugs Market Size by Application (2022-2027) & (US$ Million)
    Table 37. North America Pet Anthelmintic Drugs Market Size by Country (2016-2021) & (US$ Million) 
    Table 38. North America Pet Anthelmintic Drugs Market Size by Country (2022-2027) & (US$ Million) 
    Table 39. Europe Pet Anthelmintic Drugs Market Size by Type (2016-2021) (US$ Million)
    Table 40. Europe Pet Anthelmintic Drugs Market Size by Type (2022-2027) & (US$ Million)
    Table 41. Europe Pet Anthelmintic Drugs Market Size by Application (2016-2021) (US$ Million)
    Table 42. Europe Pet Anthelmintic Drugs Market Size by Application (2022-2027) & (US$ Million)
    Table 43. Europe Pet Anthelmintic Drugs Market Size by Country (2016-2021) & (US$ Million) 
    Table 44. Europe Pet Anthelmintic Drugs Market Size by Country (2022-2027) & (US$ Million) 
    Table 45. Asia-Pacific Pet Anthelmintic Drugs Market Size by Type (2016-2021) (US$ Million)
    Table 46. Asia-Pacific Pet Anthelmintic Drugs Market Size by Type (2022-2027) & (US$ Million)
    Table 47. Asia-Pacific Pet Anthelmintic Drugs Market Size by Application (2016-2021) (US$ Million)
    Table 48. Asia-Pacific Pet Anthelmintic Drugs Market Size by Application (2022-2027) & (US$ Million)
    Table 49. Asia-Pacific Pet Anthelmintic Drugs Market Size by Region (2016-2021) & (US$ Million) 
    Table 50. Asia-Pacific Pet Anthelmintic Drugs Market Size by Region (2022-2027) & (US$ Million) 
    Table 51. Latin America Pet Anthelmintic Drugs Market Size by Type (2016-2021) (US$ Million)
    Table 52. Latin America Pet Anthelmintic Drugs Market Size by Type (2022-2027) & (US$ Million)
    Table 53. Latin America Pet Anthelmintic Drugs Market Size by Application (2016-2021) (US$ Million)
    Table 54. Latin America Pet Anthelmintic Drugs Market Size by Application (2022-2027) & (US$ Million)
    Table 55. Latin America Pet Anthelmintic Drugs Market Size by Country (2016-2021) & (US$ Million) 
    Table 56. Latin America Pet Anthelmintic Drugs Market Size by Country (2022-2027) & (US$ Million) 
    Table 57. Middle East & Africa Pet Anthelmintic Drugs Market Size by Type (2016-2021) (US$ Million)
    Table 58. Middle East & Africa Pet Anthelmintic Drugs Market Size by Type (2022-2027) & (US$ Million)
    Table 59. Middle East & Africa Pet Anthelmintic Drugs Market Size by Application (2016-2021) (US$ Million)
    Table 60. Middle East & Africa Pet Anthelmintic Drugs Market Size by Application (2022-2027) & (US$ Million)
    Table 61. Middle East & Africa Pet Anthelmintic Drugs Market Size by Country (2016-2021) & (US$ Million) 
    Table 62. Middle East & Africa Pet Anthelmintic Drugs Market Size by Country (2022-2027) & (US$ Million) 
    Table 63. Elanco Company Details
    Table 64. Elanco Business Overview
    Table 65. Elanco Pet Anthelmintic Drugs Product
    Table 66. Elanco Revenue in Pet Anthelmintic Drugs Business (2016-2021) & (US$ Million)
    Table 67. Elanco Recent Development
    Table 68. Boehringer Ingelheim Company Details
    Table 69. Boehringer Ingelheim Business Overview
    Table 70. Boehringer Ingelheim Pet Anthelmintic Drugs Product
    Table 71. Boehringer Ingelheim Revenue in Pet Anthelmintic Drugs Business (2016-2021) & (US$ Million)
    Table 72. Boehringer Ingelheim Recent Development
    Table 73. Ceva Sante Animale Company Details
    Table 74. Ceva Sante Animale Business Overview
    Table 75. Ceva Sante Animale Pet Anthelmintic Drugs Product
    Table 76. Ceva Sante Animale Revenue in Pet Anthelmintic Drugs Business (2016-2021) & (US$ Million)
    Table 77. Ceva Sante Animale Recent Development
    Table 78. Chanelle Group Company Details
    Table 79. Chanelle Group Business Overview
    Table 80. Chanelle Group Pet Anthelmintic Drugs Product
    Table 81. Chanelle Group Revenue in Pet Anthelmintic Drugs Business (2016-2021) & (US$ Million)
    Table 82. Chanelle Group Recent Development
    Table 83. Dechra Company Details
    Table 84. Dechra Business Overview
    Table 85. Dechra Pet Anthelmintic Drugs Product
    Table 86. Dechra Revenue in Pet Anthelmintic Drugs Business (2016-2021) & (US$ Million)
    Table 87. Dechra Recent Development
    Table 88. Durvet Company Details
    Table 89. Durvet Business Overview
    Table 90. Durvet Pet Anthelmintic Drugs Product
    Table 91. Durvet Revenue in Pet Anthelmintic Drugs Business (2016-2021) & (US$ Million)
    Table 92. Durvet Recent Development
    Table 93. First Priority Company Details
    Table 94. First Priority Business Overview
    Table 95. First Priority Pet Anthelmintic Drugs Product
    Table 96. First Priority Revenue in Pet Anthelmintic Drugs Business (2016-2021) & (US$ Million)
    Table 97. First Priority Recent Development
    Table 98. Jeffers Company Details
    Table 99. Jeffers Business Overview
    Table 100. Jeffers Revenue in Pet Anthelmintic Drugs Business (2016-2021) & (US$ Million)
    Table 101. Jeffers Recent Development
    Table 102. Manna Pro Products Company Details
    Table 103. Manna Pro Products Business Overview
    Table 104. Manna Pro Products Pet Anthelmintic Drugs Product
    Table 105. Manna Pro Products Revenue in Pet Anthelmintic Drugs Business (2016-2021) & (US$ Million)
    Table 106. Manna Pro Products Recent Development
    Table 107. Merck Animal Health Company Details
    Table 108. Merck Animal Health Business Overview
    Table 109. Merck Animal Health Pet Anthelmintic Drugs Product
    Table 110. Merck Animal Health Revenue in Pet Anthelmintic Drugs Business (2016-2021) & (US$ Million)
    Table 111. Merck Animal Health Recent Development
    Table 112. Ourofino Company Details
    Table 113. Ourofino Business Overview
    Table 114. Ourofino Pet Anthelmintic Drugs Product
    Table 115. Ourofino Revenue in Pet Anthelmintic Drugs Business (2016-2021) & (US$ Million)
    Table 116. Ourofino Recent Development
    Table 117. TTK Healthcare Company Details
    Table 118. TTK Healthcare Business Overview
    Table 119. TTK Healthcare Pet Anthelmintic Drugs Product
    Table 120. TTK Healthcare Revenue in Pet Anthelmintic Drugs Business (2016-2021) & (US$ Million)
    Table 121. TTK Healthcare Recent Development
    Table 122. Vetoquinol Company Details
    Table 123. Vetoquinol Business Overview
    Table 124. Vetoquinol Pet Anthelmintic Drugs Product
    Table 125. Vetoquinol Revenue in Pet Anthelmintic Drugs Business (2016-2021) & (US$ Million)
    Table 126. Vetoquinol Recent Development
    Table 127. Virbac Company Details
    Table 128. Virbac Business Overview
    Table 129. Virbac Pet Anthelmintic Drugs Product
    Table 130. Virbac Revenue in Pet Anthelmintic Drugs Business (2016-2021) & (US$ Million)
    Table 131. Virbac Recent Development
    Table 132. Zoetis Company Details
    Table 133. Zoetis Business Overview
    Table 134. Zoetis Pet Anthelmintic Drugs Product
    Table 135. Zoetis Revenue in Pet Anthelmintic Drugs Business (2016-2021) & (US$ Million)
    Table 136. Zoetis Recent Development
    Table 137. Research Programs/Design for This Report
    Table 138. Key Data Information from Secondary Sources
    Table 139. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Pet Anthelmintic Drugs Market Share by Type: 2020 VS 2027
    Figure 2. External Features
    Figure 3. Internal Features
    Figure 4. Composite Features
    Figure 5. Injection Features
    Figure 6. Global Pet Anthelmintic Drugs Market Share by Application: 2020 VS 2027
    Figure 7. Dog Case Studies
    Figure 8. Cat Case Studies
    Figure 9. Others Case Studies
    Figure 10. Pet Anthelmintic Drugs Report Years Considered
    Figure 11. Global Pet Anthelmintic Drugs Market Size (US$ Million), Year-over-Year: 2016-2027
    Figure 12. Global Pet Anthelmintic Drugs Market Size (US$ Million), 2016 VS 2021 VS 2027
    Figure 13. Global Pet Anthelmintic Drugs Market Share by Regions: 2020 VS 2027
    Figure 14. Global Pet Anthelmintic Drugs Market Share by Regions (2022-2027)
    Figure 15. Global Pet Anthelmintic Drugs Market Share by Players in 2020
    Figure 16. Global Top Pet Anthelmintic Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pet Anthelmintic Drugs as of 2020
    Figure 17. The Top 10 and 5 Players Market Share by Pet Anthelmintic Drugs Revenue in 2020
    Figure 18. Global Pet Anthelmintic Drugs Revenue Market Share by Type (2016-2021)
    Figure 19. Global Pet Anthelmintic Drugs Revenue Market Share by Type (2022-2027)
    Figure 20. North America Pet Anthelmintic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 21. North America Pet Anthelmintic Drugs Market Share by Type (2016-2027)
    Figure 22. North America Pet Anthelmintic Drugs Market Share by Application (2016-2027)
    Figure 23. North America Pet Anthelmintic Drugs Market Share by Country (2016-2027)
    Figure 24. United States Pet Anthelmintic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 25. Canada Pet Anthelmintic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 26. Europe Pet Anthelmintic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 27. Europe Pet Anthelmintic Drugs Market Share by Type (2016-2027)
    Figure 28. Europe Pet Anthelmintic Drugs Market Share by Application (2016-2027)
    Figure 29. Europe Pet Anthelmintic Drugs Market Share by Country (2016-2027)
    Figure 30. Germany Pet Anthelmintic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 31. France Pet Anthelmintic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 32. U.K. Pet Anthelmintic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 33. Italy Pet Anthelmintic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 34. Russia Pet Anthelmintic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 35. Nordic Pet Anthelmintic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 36. Asia-Pacific Pet Anthelmintic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 37. Asia-Pacific Pet Anthelmintic Drugs Market Share by Type (2016-2027)
    Figure 38. Asia-Pacific Pet Anthelmintic Drugs Market Share by Application (2016-2027)
    Figure 39. Asia-Pacific Pet Anthelmintic Drugs Market Share by Region (2016-2027)
    Figure 40. China Pet Anthelmintic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 41. Japan Pet Anthelmintic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 42. South Korea Pet Anthelmintic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 43. Southeast Asia Pet Anthelmintic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 44. India Pet Anthelmintic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 45. Australia Pet Anthelmintic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 46. Latin America Pet Anthelmintic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 47. Latin America Pet Anthelmintic Drugs Market Share by Type (2016-2027)
    Figure 48. Latin America Pet Anthelmintic Drugs Market Share by Application (2016-2027)
    Figure 49. Latin America Pet Anthelmintic Drugs Market Share by Country (2016-2027)
    Figure 50. Mexico Pet Anthelmintic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 51. Brazil Pet Anthelmintic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 52. Middle East & Africa Pet Anthelmintic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 53. Middle East & Africa Pet Anthelmintic Drugs Market Share by Type (2016-2027)
    Figure 54. Middle East & Africa Pet Anthelmintic Drugs Market Share by Application (2016-2027)
    Figure 55. Middle East & Africa Pet Anthelmintic Drugs Market Share by Country (2016-2027)
    Figure 56. Turkey Pet Anthelmintic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 57. Saudi Arabia Pet Anthelmintic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 58. UAE Pet Anthelmintic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 59. Elanco Revenue Growth Rate in Pet Anthelmintic Drugs Business (2016-2021)
    Figure 60. Boehringer Ingelheim Revenue Growth Rate in Pet Anthelmintic Drugs Business (2016-2021)
    Figure 61. Ceva Sante Animale Revenue Growth Rate in Pet Anthelmintic Drugs Business (2016-2021)
    Figure 62. Chanelle Group Revenue Growth Rate in Pet Anthelmintic Drugs Business (2016-2021)
    Figure 63. Dechra Revenue Growth Rate in Pet Anthelmintic Drugs Business (2016-2021)
    Figure 64. Durvet Revenue Growth Rate in Pet Anthelmintic Drugs Business (2016-2021)
    Figure 65. First Priority Revenue Growth Rate in Pet Anthelmintic Drugs Business (2016-2021)
    Figure 66. Jeffers Revenue Growth Rate in Pet Anthelmintic Drugs Business (2016-2021)
    Figure 67. Manna Pro Products Revenue Growth Rate in Pet Anthelmintic Drugs Business (2016-2021)
    Figure 68. Merck Animal Health Revenue Growth Rate in Pet Anthelmintic Drugs Business (2016-2021)
    Figure 69. Ourofino Revenue Growth Rate in Pet Anthelmintic Drugs Business (2016-2021)
    Figure 70. TTK Healthcare Revenue Growth Rate in Pet Anthelmintic Drugs Business (2016-2021)
    Figure 71. Vetoquinol Revenue Growth Rate in Pet Anthelmintic Drugs Business (2016-2021)
    Figure 72. Virbac Revenue Growth Rate in Pet Anthelmintic Drugs Business (2016-2021)
    Figure 73. Zoetis Revenue Growth Rate in Pet Anthelmintic Drugs Business (2016-2021)
    Figure 74. Bottom-up and Top-down Approaches for This Report
    Figure 75. Data Triangulation
    Figure 76. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Elanco
Boehringer Ingelheim
Ceva Sante Animale
Chanelle Group
Dechra
Durvet
First Priority
Jeffers
Manna Pro Products
Merck Animal Health
Ourofino
TTK Healthcare
Vetoquinol
Virbac
Zoetis
Frequently Asked Questions
Pet Anthelmintic Drugs report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Pet Anthelmintic Drugs report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Pet Anthelmintic Drugs report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports